Contact Us

If you have a general enquiry about the company or our healthcare business, you can contact Pfizer UK by telephone on 01304 616161.


Reporting unexpected side effects

If you are taking a medicine and experience any side effects, you should immediately report these to your doctor, to another healthcare professional (such as a nurse or carer) or to the company that produced your medicine.

Likewise, if you are prescribing a medicine and become aware of any side effects, you should immediately report these to the company that produced the medicine.

If you have any concerns about a specific Pfizer medication (bearing the Pfizer logo) you can contact 01304 616161 and ask for Medical Information.

The Medicines and Healthcare Products Regulatory Agency (MHRA) can be contacted through its Yellow Card reporting system.

Please note that Pfizer is unable to provide medical advice regarding your treatment. Please consult your doctor or pharmacist who are in the best position to advise you about the suitability of a particular treatment.


Stock enquiries

Call 0345 608 8866
To talk to our Customer Contact Centre, if your query is regarding stock or product availability (for healthcare professionals only).


Questions about Pfizer prescription medicines

Chat online (click icon)
For medical enquiries on Pfizer Prescription Medicines.

Call 01304 616161
And ask to speak to the Medical Information team.

Send us your question (click icon)
For members of the general public. Complete our online form and receive a response via phone or email.

Visit our Medical Information website (click icon)
For healthcare professionals only. Access medical information and submit enquiries online.

Visit the Pfizer UK Medicine Schemes Portal (click icon)
Available for healthcare professionals to register, and place orders for medicines under GBR/MED109 and EAMS schemes.


Media Enquiries

Send your enquiry to our UK Press Office (click icon)
Please note this is only intended for journalists. Unfortunately we are unable to respond to any non-media enquiries.


PP-PFE-GBR-4235 / November 2021